Debasish Raha

Debasish Raha's work experience includes a role as Director of Biomarker and Translational Sciences at DICE Therapeutics starting in 2022. Prior to that, they worked at Cortexyme, Inc. from 2017 to 2022, holding positions as Associate Director of Translational Research and Biomarker Development, as well as Principal Scientist. At Cortexyme, they focused on translational research, biomarker discovery, and biomarker assay development for neurodegenerative disorders. Debasish also contributed to the biomarker section in an IND pharmacology-written-summary. Before joining Cortexyme, Debasish was a Senior Scientist at CytomX Therapeutics in 2016 and a Senior Scientist II at Onyx Pharmaceuticals, Inc. from 2014 to 2015. From 2010 to 2013, they worked as a Scientific Manager at Genentech, MDCCB, studying non-genetic and genetic mechanisms of resistance to targeted cancer therapies. Debasish's earliest work experience was at Yale University, where they served as a Research Scientist and Manager for the Human ENCODE Project from 2007 to 2010. In this role, they managed research activities and production work related to the identification of regulatory elements of the human genome. Debasish also played a role in developing protocols for ChIP Seq and RNA Seq.

Debasish Raha has a strong educational background in the field of science. Debasish obtained a Bachelor of Science degree in Chemistry from the University of Calcutta. Following this, they pursued a Master of Science degree in Biochemistry at the same institution. Finally, they completed their education with a PhD in Molecular Biology from Bose Institute in India.